Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KALV - KalVista Pharmaceuticals, Inc.
-84.7 M
LAST VALUE
-56.98%
2 YEAR CAGR
-4.06%
5 YEAR CAGR
-132.95%
10 YEAR CAGR